attention-deficit	is a	neurodevelopmental disorder
attention-deficit	presents with	inattention
attention-deficit	presents with	hyperactivity
attention-deficit	presents with	impulsivity
attention-deficit	associated with	executive dysfunction
attention-deficit	associated with	learning disorder
attention-deficit	associated with	anxiety disorder
attention-deficit	associated with	mood disorder
attention-deficit	associated with	sleep disturbance
attention-deficit	coexists with	oppositional defiant disorder
attention-deficit	coexists with	conduct disorder
attention-deficit	associated with	family history
attention-deficit	has	genetic component
attention-deficit	is common in	children
attention-deficit	is common in	male children
methylphenidate	is a	stimulant
amphetamine	is a	stimulant
lisdexamfetamine	is a	stimulant
atomoxetine	is a	nonstimulant
guanfacine	is a	nonstimulant
clonidine	is a	nonstimulant
methylphenidate	treats	attention-deficit
atomoxetine	treats	attention-deficit
guanfacine	treats	attention-deficit
lisdexamfetamine	treats	attention-deficit
attention-deficit	treated with	behavioral therapy
attention-deficit	treated with	cognitive behavioral therapy
attention-deficit	treated with	parent training
attention-deficit	treated with	school accommodations
attention-deficit	treated with	sleep hygiene
attention-deficit	treated with	nonpharmacologic interventions
methylphenidate	causes	appetite suppression
methylphenidate	causes	insomnia
methylphenidate	causes	weight loss
atomoxetine	causes	nausea
atomoxetine	causes	sleep disturbance
atomoxetine	causes	decreased appetite
guanfacine	causes	sedation
guanfacine	causes	dizziness
lisdexamfetamine	causes	insomnia
lisdexamfetamine	causes	appetite suppression
attention-deficit	increases	risk of accidents
attention-deficit	increases	risk of traffic accidents
attention-deficit	increases	school discipline problems
attention-deficit	associated with	poor academic performance
attention-deficit	associated with	peer problems
attention-deficit	associated with	low self-esteem
attention-deficit	increases	behavioral problems
attention-deficit	increases	family stress
ADHD	diagnosed in	childhood
attention-deficit	diagnosed using	rating scales
attention-deficit	often misdiagnosed as	learning disability
attention-deficit	misdiagnosed as	conduct disorder
attention-deficit	leads to	school suspension
attention-deficit	leads to	disciplinary action
methylphenidate	requires	monitoring
atomoxetine	requires	liver function monitoring
stimulants	are a	risk factor for insomnia
nonstimulants	are a	alternative therapy for ADHD
ADHD	has	heritability
attention-deficit	has	family history of ADHD
DRD4 gene	linked to	attention-deficit risk
DAT1 gene	associated with	attention-deficit
dopamine neurotransmission	modulated by	stimulant medications
norepinephrine neurotransmission	targeted by	atomoxetine
symptom	severity correlates with	impairment level
rating scales	used for	ADHD diagnosis
clinical guidelines	recommend	stimulant therapy as first-line
clinical guidelines	recommend	nonstimulant therapy as second-line
behavioral therapy	recommended as	nonpharmacologic treatment
parent training	improves	family functioning
school accommodations	help	academic performance
sleep disturbance	exacerbates	ADHD symptoms
ADHD	increases	risk of injuries
attention-deficit	co-occur with	sleep problems
attention-deficit	responds to	methylphenidate
attention-deficit	responds to	atomoxetine
attention-deficit	responds to	guanfacine
attention-deficit	responds to	lisdexamfetamine
preschool ADHD	management requires	caregiver involvement
adherence	improves	treatment outcomes
treatment adherence	improves	ADHD outcomes
neuropsychological testing	used for	ADHD assessment
cardiovascular evaluation	recommended before	stimulant therapy
growth suppression	potential result of	stimulant treatment
weight loss	potential side effect of	stimulant
liver function tests	recommended during	atomoxetine therapy
neuroimaging findings	show	reduced prefrontal activation
ADHD	associated with	depression in adolescence
ADHD	associated with	substance use disorders
treatment adherence	predicts	ADHD outcomes
family support	improves	treatment adherence
substance use disorder	risk increased with	ADHD
attention-deficit	influences	school disciplinary outcomes
academic performance	predictor of	future outcomes
children with ADHD	require	school-based supports
teacher reports	facilitate	ADHD identification
screening tools	have	validity for ADHD detection
neuroimaging	supports	ADHD diagnosis
treatment adherence	improves	ADHD outcomes
